Compounds > 2,3,4,5-tetrahydroxypentanal

2,3,4,5-tetrahydroxypentanal and transforming growth factor beta

2,3,4,5-tetrahydroxypentanal has been researched along with transforming growth factor beta in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cachofeiro, V; Calvier, L; Fernández-Celis, A; Ibarrola, J; Leroy, C; López-Andrés, N; Martínez-Martínez, E; Rossignol, P	1

Other Studies

1 other study(ies) available for 2,3,4,5-tetrahydroxypentanal and transforming growth factor beta

Article	Year
Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats. Journal of hypertension, 2018, Volume: 36, Issue:2 Topics: Actins; Acute Kidney Injury; Acute-Phase Proteins; Albuminuria; Animals; Antigens, CD; beta Catenin; Blood Pressure; Cell Line; Chemokine CCL2; Collagen Type I; Connective Tissue Growth Factor; Creatinine; Epithelial-Mesenchymal Transition; Fibronectins; Fibrosis; Galectin 3; Hypertension; Kidney; Kidney Diseases; Lipocalin-2; Lipocalins; Male; Organ Size; Osteopontin; Pectins; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Transforming Growth Factor beta; Up-Regulation	2018

Article

Year

Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats.

Journal of hypertension, 2018, Volume: 36, Issue:2

Topics: Actins; Acute Kidney Injury; Acute-Phase Proteins; Albuminuria; Animals; Antigens, CD; beta Catenin; Blood Pressure; Cell Line; Chemokine CCL2; Collagen Type I; Connective Tissue Growth Factor; Creatinine; Epithelial-Mesenchymal Transition; Fibronectins; Fibrosis; Galectin 3; Hypertension; Kidney; Kidney Diseases; Lipocalin-2; Lipocalins; Male; Organ Size; Osteopontin; Pectins; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Transforming Growth Factor beta; Up-Regulation

2018